Hebang Biotech (603077.SH) announced results for the first three quarters, with net profit of 454 million yuan, an increase of 387.48% over the previous year

Zhitongcaijing · 2d ago

Zhitong Finance App News, Hebang Biotech (603077.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 4.522 billion yuan, a year-on-year decrease of 23.70%; net profit attributable to shareholders of listed companies was 454 million yuan, an increase of 387.48%; after deducting non-net profit of 447 million yuan, a year-on-year increase of 398.60%; and basic earnings per share were 0.0554 yuan.